Avalo Therapeutics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $35 Price Target
在奧本海默將股票從表現上調至跑贏大盤並宣佈35美元的目標股價之後,Avalo Therapeutics的股價走高
Avalo Therapeutics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $35 Price Target
在奧本海默將股票從表現上調至跑贏大盤並宣佈35美元的目標股價之後,Avalo Therapeutics的股價走高
使用瀏覽器的分享功能,分享給你的好友吧